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Abstract
Valinomycin and cereulide are toxic cyclic ionophoric peptides produced by bacteria
found in food and/or the environment. Valinomycin is produced by several species
of Streptomyces, whereas cereulide is produced mainly by Bacillus cereus.
Valinomycin and cereulide act as carriers of potassium ions through biological mem-
branes. They are highly lipophilic and will therefore passively penetrate into tissues
and cells, causing a health hazard. These toxins are stable and no method is known
to destroy them in food or the environment.
Cereulide is produced by certain strains of B. cereus frequently present in food, for
example in rice and beans. Valinomycin is structurally related to cereulide but is pro-
duced by Streptomyces griseus, commonly isolated from moisture-troubled buildings.
Occupants of these houses suffer from an excess of trivial infections.
This study deals with the effects of cereulide and valinomycin on one part of the
human immune system, natural killer cells (NK cells), known to be involved in de-
fence against microbial infections and malignant disease.
NK cells represent 5-20% of peripheral blood lymphocytes and are capable of killing
abnormal cells without prior activation. Activated NK cells also secrete cytokines,
such as interferon gamma (IFN-γ), to regulate other arms of the immune system.
Valinomycin and cereulide were toxic to normal human NK cells, as measured by the
reduction of the NK activity, increased apoptosis, and diminished cytokine produc-
tion. The toxic effect was seen with very low, physiologically relevant concentrations
of bacterial toxins. To our knowledge, this is the first time that such toxin effects were
shown with normal human white blood cells.
Exposure to the toxins changed the morphology of normal human NK cells and a cultured
NK cell line. Vacuole formation was clearly observed with light microscopy and in trans-
mission electron microscopy, and mitochondrial swelling was seen after cereulide or
valinomycin treatment. In addition, the surface projections normally occurring on human
NK cells became shorter and thicker, as shown by scanning electron microscopy.
IFN-α, one of the most abundant cytokines released by virus-infected cells, in combina-
tion with IL-18 induced stimulation of IFN-γ production of NK cells. Additionally IL-12,
-15, and -18 synergistically induced IFN-γ production, and protected NK cells from the
toxic damage of valinomycin or cereulide. Interestingly, T cells and monocytes were not
as sensitive as NK cells to these toxins.
The present results demonstrated for the first time that resting NK cells express high cas-
pase-3 activity. Valinomycin treatment did not change this activity. Valinomycin induced
two pathways of apoptosis in the NK cells; one of which was the caspase-3-dependent
‘classical’ pathway of apoptosis, and the other was the caspase-3-independent ‘non-clas-
sical’ pathway.
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1. Introduction
This thesis describes interactions of NK cells with their environment and with two
toxins, valinomycin and cereulide. Valinomycin and cereulide are lipophilic cyclic
peptides and ionophores, produced by bacteria. These ionophorical toxins may cause
imbalance in cellular potassium equilibrium. Humans may become exposed to vali-
nomycin and cereulide via everyday food or via indoor air, especially in buildings
with dampness damage. People living or working in such buildings are reported to
continuously suffer from respiratory infections [1, 2]. The introduction describes the
three main elements of this study, the two toxins and human NK cells. It also intro-
duces the physical and physiological environments where the immune defence cells
operate and interact with intercellular messengers and toxic bioactive substances.
1.1 Potassium equilibrium in cells
Potassium ions are essential to living cells. Their transport is part of cellular signal-
ling, creates electrical potentials in the cells, and also contributes to the cellular osmot-
ic balance. Potassium ions are positively charged, and are transported through bio-
logical membranes by active transport systems like ATP sensitive Na+-K+ pumps or
voltage gated channels, to maintain the cellular potassium equilibrium. Inside nor-
mal animal cells the K+ concentration is 140 mmol/l, approximately 30 times higher
than outside (4 mmol/l) [3].
1.1.1 Na+-K+ pumps
ATP dependent Na+-K+ pumps are present in the plasma membranes of all animall
cells. These membrane-spanning proteins work as ATPases and antiporters, transport-
ing three Na+ ions out and two K+ ions in to cells against their electrochemical gradi-
ents with the expense of ATP being hydrolyzed to ADP. These pumps use up to 70%
of cellular ATP. The other important task of these pumps is to maintain the osmotic
balance and stabilize the cell volume [3, 4]. (Figure 1)
1.1.2 Potassium channels
Ion channels allow ion leakage downstream of the ionic gradients through the mem-
brane by special pores. These channels are ion-selective; i.e. they select for K+ over Na+
based on the specific ion dimension or on the hydrated ion size (Figure 2).
Ions can pass through these channels at a rate 105 higher when that conducted by
transporters. High voltage stimuli open the gates of the potassium channels. Af-
ter cessation of the stimuli the channels are inactivated and closed. This type of
channel is typical for excitable cells such as nerve cells. There are also Ca2+-acti-
vated K+ channels in nerve cells, opened by elevated Ca2+ concentrations on the
cytoplasmic side of the nerve cell membrane (Ca2+ can be elevated inside nerve
cells because of voltage-gated Ca2+ channels). [4]
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Figure 1. Na+-K+ ATPase and Na+-K+ equilibrium in an animal cell. The pump
maintains the intracellular concentrations of potassium and sodium ions, and
generates the transmembrane electrical potential. Modified from Nelson et al.
[3]
Figure 2. Sizes of hydrated cations, modified from Stryer [5].
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1.2 K+ ionophoric bacterial toxins
Bacteria can produce toxins to help them survive in certain environments. Bacterial-
ly produced ionophores can disrupt the human cellular Na+-K+ equilibrium by trans-
porting K+ ions downstream of their electrical or concentration gradients, which are
maintained by membrane sodium-potassium pumps [4].
Several different taxa of microorganisms are known to produce K+ ionophores (Table
1) [6, 7]. These are known to function as carriers or as channel formers [6]. Nonactin,
nigericin, valinomycin, cereulide, and polyether ionophores are ion carriers where-
as alamethicin and gramidicin form special ion transporting channels in the biolog-
ical membranes [6, 8, 9] (Table 1).
Table 1. Various K+ ionophores produced by microorganisms
Compound Transported ions Transport type Producers and structure Ref.
Valinomycin K+, Rb+ Mobile carrier Streptomyces griseus,
S. tsusimaensis, S. fulvissimus,
peptide b
Nonactin NH
4
+, K+ Mobile carrier Streptomyces sp. c
Cereulide K+ Mobile carrier Bacillus cereus, peptide b
Nigericin K+,H+ Mobile carrier S. hygroscopicus, polyether a
Salinomycin K+ Mobile carrier S. albus, polyether a, b
Lasalocid K+, Ca2+ Mobile carrier S. lasaliensis, polyether a
Enniatin NH
4
+, K+ Mobile carrier Fusarium sp., peptide a, b
Narasin K+ Mobile carrier S. aureofacians a, b
Gramidicin H+, Na+, K+ Channel former Brevibacillus brevis b, c
Alamethicin K+, Rb+ Channel former Trichoderma viride
a [6], b [7], c [9]
Some antimicrobial drugs act as ionophores. Examples of such antimicrobials, in
everyday use in Europe and in the USA as additives in the animal feed industry, are
the potassium ionophores narasin, salinomycin, and lasalocid. These three ionophores
are used as coccidiostats, i.e. as prophylaxis towards certain unwanted gastrointes-
tinal parasites (coccidiosis, caused by Eimeria sp ). Salinomycin is also a growth pro-
moter [8]. In Finland these three antimicrobials are used for poultry, but in some coun-
tries they can also be used for dairy and beef cattle and pigs [10-12].
In many EU countries, animal products (milk, meat, and eggs) are tested for antibi-
otic residuals. Amounts below the action levels (set by food safety authorities) are
frequently reported [10, 13] (Table 2). Addition of lasalocid to poultry feed in Finland
was interrupted in the spring of 2003 after two lasalocid positive eggs were found [13].
When narasin and salinomycin were tested for inhibition of boar sperm, as a test to
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detect mitochondriotoxins, sperm motility inhibition was observed exposure concen-
tration of 50 ng/ml. Cereulide, valinomycin, and lasalocid were the most toxic to
sperm, inhibiting the sperm motility with exposure concentrations of 0.5-2.5 ng/ml
(unpublished results of Hoornstra) [7].
Table 2. Potassium ionophoric growth promoters and coccidiostats used in the
livestock industry
Ionophore
Lacalocid/
lasalocid
Salinomycin
Narasin
Countries
EU nations
USA
EU
countries
USA
EU
countries
USA
Animals
Poultry,
eggs
Cattle
Poultry,
ducks,
eggs,
pigs
Poultry,
ducks,
eggs
LOD
(limit of
detection)
25 µg/ kg/
Finland/
EU
0,4-24,8
µg/ kg/
Denmark
10 µg/ kg/
Finland/
EU
10 µg/ kg/
Finland/
EU
Action level
Positive
detection
25 µg/ kg/
Denmark
positive
detection/
EU
positive
detection
Positive findings
2 egg samples /
Finland 2002
Also in Austria,
United Kingdom,
Belgium, and
Germany
Denmark
Sweden
Ref.
a, b, c
a, b, c, d
a, b, c
a [13], b [10], c [12], d [8]
Two ionophoric bacterial toxins, valinomycin emitted by strains of Streptomyces gri-
seus into indoor air, and cereulide produced by strains of Bacillus cereus, were inves-
tigated in the present study. Both toxins are highly effective and mobile carrier iono-
phores selective for K+ over Na+, at a ratio of 1000:1 [9] [14]. Both toxins are uniporters,
carrying only one ion at a time across membranes [9].
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1.2.1 Valinomycin produced by Streptomyces species
Valinomycin belongs to the peptide antibiotics, synthetisized by a multienzyme
complex in different species of Streptomyces such as S. levoris, S. tsusimaensis, S. livi-
dans, S. fulvissimus, S. griseus, and S. coelicolor [7, 15]. Valinomycin has been known
for a long time. It is a cyclic ionophoric dodecadepsipeptide, transporting potas-
sium ions selectively through mitochondrial membranes [9, 16] (Figure 3). This
selectivity for potassium ions is due to the exact fit of the cavity inside the cyclic
shape of the valinomycin molecule and the ability of different amino- and 2-hy-
droxyacids to hold K+ there [17]. Cereulide is chemically closely related to valin-
omycin but differs in biological activity; it causes emetic illness in humans, while
valinomycin does not [18].
Valinomycin is stable. Its biological activity is not destroyed by cooking, heating or
treating by extreme pH. It is also very lipophilic (log K
ow
= 5,99), which enables pas-
sive penetration through biological membranes, thus increasing toxicity [1, 14]. This
penetration causes K+ ions to flow downstream the electrical potential, from cyto-
plasm to mitochondria, and depolarization of mitochondria and hyperpolarization of
the plasma membrane [7].
Valinomycin has been shown to induce apoptosis in numerous human and murine
cell lines, such as BAF3 and P-815, at relatively high exposure concentrations (µg/ml).
Evidence shows how valinomycin dissipates the mitochondrial electric transmem-
brane potential and induces collapse of the mitochondrial outer membrane, which
then initiates apoptosis [19, 20]. Inai et al. [21] revealed that valinomycin collapsed the
mitochondrial electric transmembrane potential of rat ascites hepatoma cells (AH-130)
and activated caspase-3 like proteases, initiating apoptosis at exposure concentrations
as low as 100 ng/ml. Other investigators also reported apoptosis in rat cells and dif-
ferent cell lines of human origin, but induction of apoptosis in normal cells by valin-
omycin has not been described before.
1.2.2 Cereulide produced by Bacillus cereus
Cereulide is a recently found peptide toxin, structurally related to valinomycin [24, 25]
(Figure 4). It transports potassium ions and is highly lipophilic (log K
ow
= 7,46) [1, 14].
Bacillus cereus is a frequent contaminant of everyday food, especially of starchy foods
like rice but also dairy products, eggs, vegetables, and cereal products [26, 27].
Cereulide producing strains of B. cereus are reported in rice and pasta foods, but only
seldom in dairy products [28, 29]. There are cases in which skin contact with B. cereus
contaminated foodstuff resulted in emetic disease. Direct penetration of the toxin
through the skin was suggested [30].
B. cereus, like other Bacillus species, forms heat resistant spores which are difficult
to destroy. It is mesophilic and some strains are psychrotolerant, growing between
+4 and +7°C. B. cereus strains can produce numerous different toxins, for exam-
ple hemolysins, enterotoxins, and phospholipases, of which cereulide is one of the
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most harmful [28]. The reason is the same as with valinomycin, it is highly li-
pophilic, chemically stable, and impossible to inactivate [1]. Only specific class-
es of B. cereus strains can produce cereulide. The diarreal enterotoxin producer
strains do not produce cereulide [26].
K+
K+
K+
K+
K+
Extracellular side
Cytosolic side
Ionophore
Figure 3. A. The structure of valinomycin molecule associated with K+ ion.
Modified from Ovchinnikov [22]. The hydrophilic groups in the cavity of
valinomycin molecules hold K+ ions during transportation [9]; B. Model of
valinomycin molecule with the K+ ion [23]; C. Model of K+ ion transportation across
a biological membrane by valinomycin. Modified from Devlin [9].
The production of cereulide was reported to be increased when food was stored
at a temperature of over 30°C. At 35°C B. cereus strain NC7401 produced over 2000
ng/g cereulide in boiled rice within 24 hours [31]. Finlay et al. [32] investigated
skim milk and concluded that the toxicity of B. cereus F4810/72 extracts to Hep2
cells was highest at temperatures from 12 to 15°C. It was recently shown that
A B
C
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cereulide concentrations may reach 300 to 600 ng/g in bakery products within 4
days of storage at 21 to 23°C. The normal shelf life of bakery products ranges from
4 to 75 days, depending on the product. Cool storage (≤ 8°C) was reported to pre-
vent cereulide production. Bakery products containing rice or rice starch accumu-
lated as much as 5.5 µg/g of cereulide when a cereulide producing B. cereus strain
was present. White bread stored under similar conditions contained only 0.006
µg/g of cereulide [33].
Food poisoning by B. cereus may even be fatal, and causes emetic illness all over the
world. Because B. cereus poisonings are not reportable diseases, the published values
of B. cereus related cases, 1 to 47% of all food poisonings, are inaccurate, underestima-
tions or overestimations, and even include those caused by viruses [27, 34].
Cereulide causes nausea and vomiting in primates and in the shrew Suncus murinus
[25, 35, 36]. Yokoyama et al. [37] showed that rodents were insensitive to orally giv-
en cereulide, but the intraperitoneally injected synthetic cereulide caused the same
kind of morphological changes as in human. Pathological changes were observed in
the mice livers 2 to 3 days after cereulide treatment, but in the survivors changes dis-
appeared after 4 weeks as measured by serum hepatic enzyme levels and histopatho-
logical analyses.
Figure 4. Structures of cereulide molecules interacting with K+ ions. A , B [38]
and C [18]
A B
C
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Harmful effects of cereulide are clearly visible at the cellular level. Cereulide causes
mitochondrial swelling in HEp-2 cells, and hence is termed vacuolation factor [39].
Similar to valinomycin, the K+ ionophoric property of cereulide causes the mitochon-
dria to swell. This mitochondrial swelling may result from inflow of K+ ions from the
cytoplasm along the electrical gradient towards the negatively charged mitochondrial
interior [14, 24]. This mechanism is supported by the observation that the cytoplasm
of sperm cell became hyperpolarized in response to cereulide exposure — reflecting
the loss of positively charged K+ from the cytoplasm [7].
1.3 NK cells
NK cells form the third major subpopulation of lymphocytes, comprising 5 to 20%
of peripheral blood lymphocytes. Upon activation NK cells migrate into tissues.
For example, during inflammatory conditions they are found in lung and liver pa-
renchyma [40]. NK cells originate from a common precursor with T cells, but do
not require thymic influence for maturation. Most NK cells express a
CD3–CD16+CD56+ phenotype, but are heterogeneous, and at least 48 different sub-
types have been described [41].
Morphologically, NK cells are medium to large sized granular lymphocytes with a
high cytoplasm to nucleus ratio like activated T lymphocytes [42]. The nucleus is often
kidney shaped. The cytoplasm of NK cells contains a relatively abundant number of
mitochondria compared to, for example, T cells [40].
1.3.1. Receptors
NK cells express many different activating and inhibitory receptors, which maintain
the delicate balance of positive and negative signals to the cytolytic machinery (Fig-
ure 5). The ligands for these receptors are classical and nonclassical MHC I molecules.
The killer cell immunoglobulin like receptor (KIR) family recognizes and binds the
classical MHC I molecules. Some of these receptors mediate inhibition of NK cell
cytotoxicity, while the functions and ligands of other receptors are still unknown [43].
The nonclassical MHC I molecule HLA-E is recognised by the lectin-like CD94/NKG2
receptor family. Both receptor families contain both inhibitory and stimulatory forms.
An individual NK cell can simultaneously express several activating and inhibitory
receptors. Most NK cell receptors are encoded by the NK-gene complex and leuko-
cyte-receptor complex [44]. Other surface molecules, such as CD11a/CD18, 2B4, CD2,
and CD69, may induce or modulate NK cell functions, too [44]. (Figure 5).
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1.3.2. Functions
NK cells have many important functions. They kill abnormal cells without prior ac-
tivation, including tumor cells, virus- and other pathogen-infected cells. They recog-
nise these target cells through their surface receptors (Figure 5B). The lytic machin-
ery of NK cells operates mainly through a pore-forming protein, perforin, and the
proteolytic granzymes A and B [40, 42].
One NK cell is able to kill more than one target cell, although this ability is limited.
After a certain number of killing cycles, NK cell apoptosis is induced through the
killer receptors [45].
Another main function of NK cells is the protection against viral infections. As NK cell
deficient patients usually suffer from severe herpes virus infections, it has been sug-
gested that NK cells are especially effective against this group of viruses [46].
Furthermore, NK cells produce cytokines such as interferon gamma (IFN-γ) (Figure
6), tumor necrosis factor-α (TNF-α), lymphotoxin, IL-3, -5, -8, -10, -13, and granulo-
cyte macrophage colony-stimulating factor (GM-CSF), after being stimulated by var-
ious cytokines [46]. NK cells produce these cytokines to regulate other cells in the
immune system and also for autocrine regulation. For example, IL-2 and IL-15 induce
proliferation of NK cells, and IL-12 and IFN-γ  stimulate NK cell cytokine production [47].
1.4 Cytokines and interferons in the NK cell system
Cytokines are part of the soluble mediators in the regulation of immune defence. The
cytokines regulate differentiation, proliferation and also cytokine production of var-
ious cell types. Cytokines are small, non-structural, intercellular regulatory proteins.
Interleukins and interferons are central components of the cytokine system. At least
29 interleukins and four interferons are currently known, and the number of inter-
leukins increases continuously [48-52].
The pattern of interferon and cytokine production by NK cells facilitates the Th1 re-
sponse (CD 4+ T helper cell response), which means that NK cells produce Th1-type
cytokines, like IFN-γ after stimulation by IL-12 and IL-15. At same time they do not
produce Th2 (type 2 T helper cell) response cytokines, such as IL-4. For the Th2 re-
sponse, NK cells need a priming IL-4 stimulus. Th2 response is known to be associ-
ated with allergy. The early Th1 response begins with phosphorylation of a signal
transducer and an activator of transcription 4 (Stat 4), whereas the Th2 response be-
gins with Stat 6 phosphorylation [53, 54].
1.4.1 IFNs and GM-CSF on NK cells
The IFN-γ stimulates immune cells to mediate immune defence, especially Th1 re-
sponse, against intracellular infections like those by viruses. Therefore, impairment
of IFN-γ production often leads to decreased resistance to viral infection [42].
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Figure 6. IFN-γ production by NK and T cells. IFN-γ is a regulator of many different
cell types, including NK and T cells. Modified from Hunt [60].
Figure 5. A. Inhibitory and stimulatory receptors of NK cells. B. Mechanisms of
inhibition and activation of NK cell. Modified from Yokoyama et al.[44].
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After human cells are infected by viruses they produce type I interferons (IFN-α/β),
which enhance NK cell killing ability towards virus-infected cells [55]. IFN-α also ac-
tivates human Th1-type immune responses through Stat4, which leads to IFN-γ gene
expression in T cells [56]. After viral infection, macrophages produce IFN-α/β and IL-
18, which together can enhance IFN-γ gene expression in T cells [57].
GM-CSF is another cytokine produced by NK cells after stimulation [58]. GM-CSF
directs granulocyte and macrophage colonies towards maturation. Monocytes and fi-
broblasts also produce GM-CSF [59].
1.4.2 IL-12
IL-12 is member of a small heterodimeric cytokine family with two other recently
discovered interleukins -23 and -27 [49]. IL-12 is produced by phagocytic cells and
dendritic cells after microbial infection. Many cell types express IL-12 receptors, but
the receptors are most abundant on NK cells and on activated T cells. IL-12 induces
proliferation, cytotoxicity, and IFN-γ production [61, 62]. IL-12 works synergistically
with IL-18 in the induction of NK and T cell proliferation [63, 64].
Table 3. NK cells and selected cytokines
Cytokines affecting NK cells The resulting effect of NK cell
functions
Effector cell Produced cytokine
T cells
monocytes/ macrophages
monocyte/macrophage,
dendritic cells human bone
marrow stromal cells
macrophage dendritic cells
T helper cells
NK and T cells
NK cells
IL-2a
IL-12b
IL-15c,a
IL-18d
IL-21e
IFN-γ f
GM-CSFg
Stimulates proliferation and differentation
Stimulates Th1 differentation, inhibits Th2
differentation
Stimulates NK cell proliferation and
differentation
Stimulates maturation, cytokine
production, and cytotoxicity
Enhances cytolytic activity
Facilitates Th1 response
Stimulates granulocyte and macrophage
colonies growth and differentiation
a [48], b [62], c [65], d [50], e [66], f [42], g [59]
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1.4.3 IL-15 and IL-2
The most important function of IL-15 is to initiate the differentiation of NK cells and
T cells from progenitor cells in the bone marrow [65]. IL-15 may be the critical inter-
leukin for the in vivo survival of the NK cells [67, 68]. IL-15 shares a part of its heter-
otrimeric receptor with IL-2. IL-2 is homologous with IL-15, with which it shares
many functions. The difference is that IL-15 more broadly enhances NK cell functions
than does IL-2, and IL-15 has a wider tissue distribution [65]. IL-15 is produced by
many tissues and cells, such as monocytes, macrophages, dendritic cells, and bone
marrow stromal cells [65].
1.4.4 IL-18
IL-18 is another important cytokine regulating NK cells. IL-18 is produced, for exam-
ple, by macrophages, dendritic cells, and keratinocytes. In addition to NK cells, many
other cells also express IL-18 receptors. The main function of IL-18 is to stimulate
response against microbial infection. IL-18 activates and facilitates many functions of
NK cells, such as maturation, cytotoxicity, and cytokine — especially IFN-γ — produc-
tion [50, 63]. IL-18 is often a co-stimulatory cytokine along with IL-15 or IL-12. Syn-
ergy of these cytokines increases the rate of IFN-γ production and proliferation of NK
cells [63, 64].
1.4.5 IL-21
IL-21 is a recently discovered cytokine produced by activated CD4+ T cells [51]. T, B,
and NK cells express IL-21 receptors. This interleukin may elicit inhibitory or stimu-
latory effects on NK cells. It can stimulate cytolytic activity alone or synergistically
with IL-15, and expand the NK cell pool of the bone marrow or of peripheral blood.
High doses of IL-21 inhibit IL-2 induced NK cell proliferation whereas low doses may
stimulate it [66]. According to Strengell et al. [69] IL-21 acts synergistically with IL-
15 and IL-18 in stimulating NK and T cell IFN-γ production.
1.5 Caspase-3
Caspase-3 is a cysteine aspartate protease. Caspase-3 has traditionally been regard-
ed as a key regulator of apoptosis. Recently however, part of apoptosis has been no-
ticed to be caspase-3-independent. The two apoptotic mechanisms, caspase-3-depend-
ent and caspase-3-independent, may operate simultaneously [70]. Caspase-3 activity
is also involved in the proliferation of T cells [71].
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1.5.1 Caspase-3 dependent apoptosis
Cells can be destroyed by necrosis, or they can die through apoptosis i. e. programmed
cell death. In apoptosis the cells themselves launch a cascade, which causes typical
morphological apoptotic changes to cells, such as DNA degradation, cell shrinkage,
and membrane blebbing [72]
The ‘classical’ caspase-dependent route includes two pathways, the extrinsic and
intrinsic ones. The extrinsic pathway is triggered by death receptors such as Fas or
TNF receptors. It is mediated by Fas-associated death domain protein (FADD), which
cleaves initiator caspase-8 to its mature form. Caspase-8 cleaves procaspase-3 to pro-
duce mature caspase-3 [72, 73]. Caspase-3 cleaves the inhibitor of caspase-activated
DNAse (ICAD) from the CAD:ICAD complex, allowing caspase-activated DNAse
(CAD) to cleave chromosomal DNA [74].The intrinsic pathway of apoptosis cascade
begins from the mitochondrial membrane disruption. This leads to the leakage of
cytochrome c from the mitochondria and to the consequent clustering of apoptosis-
activating factor 1 (Apaf-1) with caspase-9. This cluster is called an apoptosome. The
apoptosome converts the precaspase-3 into its mature form [72, 73]. (Figure 7).
Figure 7. Apoptosis pathways. The two caspase-dependent pathways; the extrinsic
pathway is triggered via Fas, and the intrinsic one is triggered by apoptotic stimuli.
Apoptotic stimuli can also trigger caspase-independent apoptosis when AIF or
endo G from damaged mitochondria initiate apoptosis.
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1.5.2 Caspase-3 independent apoptosis
Parallel to caspase-3-dependent apoptosis, there exists another type of programmed
cell death, which does not require caspases. This is generally called the ‘non-classi-
cal’ pathway. This type of apoptosis has been described to occur in many cell types,
such as human neutrophils, T cells, COS, U937, Rat-1, and rat hepatoma 512tc cells,
among others [70, 75-77]. In many cases apoptosis is initiated by apoptosis-inducing
factor (AIF), which is released from a damaged mitochondrion. This initiator does not
trigger the caspase cascade nor regulate it, but instead triggers caspase-independent
apoptosis [76, 78]. Recently Li et al. [79] found a new apoptosis factor from mitochon-
dria, which can induce caspase-independent apoptosis. This endonuclease G initiates
DNA fragmentation independently from caspase-3.
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2. Aims of this study
The specific goals were to:
2.1 Elucidate details of interleukin regulation of central NK cell functions.
2.2 Measure the effects of the potassium ionophoric peptide toxins, valinomycin
and cereulide, on NK cell functions such as cytotoxicity, IFN-γ  production, and
apoptosis.
2.3 Investigate the apoptotic effect of these toxins on NK cells.
2.4 Discuss the consequences of human exposure to microbially produced potas-
sium ionophores like cereulide, valinomycin, lasalocid, salinomycin and narasin.
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3. Materials and methods
Materials and methods used in this study are listed in table 4.
Table 4. The methods used in this study
Assay Described in papers Reference
Purification of peripheral blood mononuclear cells (PBLs) I, II, III, IV
Cell cultures (NK-92, HeLa, HepG2, and K-562) I, II, III, IV [80]
Cytokine activation of NK and T cells I, II, III, IV
51Cr-release cytotoxicity assay I, II, IV [81]
Electron microscopy (SEM and TEM) I, II [82]
NK cell exposure to bacterial toxins I, II, IV
Annexin-V-apoptosis assay I, II, IV [83]
Fluorescence JC-1 staining assay II [84]
IFN-γ ELISA assay I, II, III, IV
GM-CSF ELISA assay I
Purification of cereulide from Bacillus cereus II
Identification of cereulide by specific mass ions by II
ESI-MS and ESI-MS/ MS
RNA isolation and analysis III
DNA isolation and analysis III, IV [83]
Caspase-3 assay IV
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4. Results and discussion
4.1 The effects of different cytokines on NK cells
The effects of IFN-α, IL-12, IL-15 and IL-18, applied separately or in various combi-
nations on NK cell IFN-γ and GM-CSF productions were studied.
It is already known that in virus infected T cells IFN-α and IL-18 synergistically en-
hance IFN-γ production [57]. Furthermore, Sareneva et al. 2000 [85] reported that IFN-
α and IL-12 induce IL-18 receptor gene expression in T cells and in NK cells.
In the present study, NK, T, and NK-92 cells were first stimulated either with IFN-α
plus IL-18 or with IL-12 plus IL-18. The effects were then monitored by measuring the
amount of IFN-γ production (by ELISA-assay) and the kinetics of IFN-γ mRNA syn-
thesis (by Northern blotting).
Next, the effect of IL-12, -15 and -18 in various combinations on cytokine production
of NK cells was studied. It was also examined how the two environmental bacterial
toxins, cereulide and valinomycin, affected the interferon stimulated IFN-γ and GM-
CSF production by NK cells.
4.1.1 NK cell responses to cytokine stimulation
The results in Paper I show that IFN-α and IL-18 enhanced IFN-γ production of pu-
rified resting human NK cells in a synergistic manner. Stimulation of NK cells by IFN-
α or by IL-18 separately elicited only a low IFN-γ production, <100 pg/ml. When NK
cells were stimulated with a combination of IFN-α and IL-18, the IFN-γ production
was much higher, >2000 pg/ml. The combination of IL-12 and IL-18 also induced high
IFN-γ production, up to >40000 pg/ml, as compared to stimulation with a single in-
terleukin, resulting in the production of <1000 ng/ml. These results are shown in
details in Figure 1, Paper III.
The difference between the effects of IL-12 plus IL-18 and IFN-α plus IL-18 stimula-
tions was reflected in the kinetics of the IFN-γ production by NK cells. IFN-γ produc-
tion induced by IFN-α plus IL-18 was highest at the 6 h time point and remained el-
evated until 20 h, as compared with IL-12 plus IL-18 induced stimulation, which
continued to increase for up to 20 h (Figure 2A, Paper I). This difference in the kinet-
ics was also seen in the expression level of IFN-γ mRNA. IFN-α when applied alone,
stimulated the IFN-γ gene expression up to its peak value in 2 to 3 h. The IFN-α-in-
duced IFN-γ mRNA level decreased rapidly, whereas the IL-12-induced IFN-γ mRNA
levels continued to increase during the 10 h experiment. (Figure 4, Paper III). All ef-
fects observed in the IFN-γ production by NK cells were also seen in T cells (Paper I).
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The results described above indicate that immune defence involves more than one
efficient pathway to produce needed IFN-γ to counteract infections by bacteria or by
viruses. The production of IFN-γ by NK cells or T cells is lower in viral infections
(shown by IFN-α plus IL-18) than in bacterial infections (shown by IL-12 plus IL-18).
This may suggest that viruses are more susceptible than bacteria to IFN-γ-induced
immune defence or maybe γ-IFN is needed for much lower concentrations to induce
the necessary defence against viral infections.
The present results demonstrated the synergism of IL-12, -15 and -18 in IFN-γ and
GM-CSF production by NK cells. IL-15 alone stimulated IFN-γ production up to 20
000 pg/ml, whereas IL-18 induced IFN-γ production was around 1000 pg/ml. The
combination of these two interleukins, however, was synergistic, increasing the IFN-
γ production up to 40 000 pg/ml. The influence was similar on GM-CSF: the syner-
gy of IL-15 and IL-18 made NK cells to produce at least twice as much GM-CSF as
compared with either of these interleukins alone. (Figure 5, Paper II).
IL-12 alone stimulated only a low level of IFN-γ production. However the simultane-
ous effect of the combinations of IL-12 with IL-15 or IL-12 with IL-18, stimulated γ-
IFN production significantly (p ≤ 0.05). Simultaneously adding all three interleukins
resulted in IFN-γ production that was at least twice as high as that observed with the
combination of two interleukins only, as shown in Figure 7, Paper III.
In vivo conditions are difficult to imitate in vitro, but the results do suggest that tun-
ing of the immune system to its maximal capacity requires the combination of several
cytokines. The optimal cytokine combination is probably dictated by the type of in-
fection or noxious stimulation.
4.1.2 Effects of valinomycin and cereulide on cytokine stimulation
Various environmental exposures can harm immune functions. Here it was shown
how two bacterial K+ ionophoric toxins, valinomycin and cereulide, hampered IFN-
γ and GM-CSF production by NK cells. NK cells were first exposed for 2 h to valino-
mycin or cereulide, simulating a situation where toxin-producing bacteria infect the
host. The IFN-γ production by toxin-treated NK cells was strongly reduced when they
were incubated with any of the interleukins alone; only modest IFN-γ production was
seen. But interestingly, when the toxin-treated NK cells were incubated with a com-
bination of interleukins, a substantial recovery of IFN-γ production was evident. The
same result was seen also on GM-CSF production. (Figure 5, Paper II).
Cereulide was equally toxic as valinomycin to NK cells, as demonstrated by in the
dramatic reduction of IFN-γ production by exposed cells. Recovery of IFN-γ produc-
tion was efficient under influence of the combination of IL-15 and IL-18, and even
more efficient when all three interleukins (IL-12, -15 and -18) was used to stimulate
the NK cells after the toxin treatment (Paper III, figure 7).
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NK cells were more sensitive to toxins than were T cells and monocytes. The toxic
effect on T cells came later, after 72 h culturing, as compared to the 24 h when the NK
cell had been exposed. Monocytes were not sensitive to valinomycin, or cereulide
(Figure 7, Paper III).These results suggest that valinomycin and cereulide are toxic
primarily to NK cells. The results also showed that cereulide was somewhat less toxic
than valinomycin as measured by IFN-γ production by NK cells.
4.2 Toxin effects on the cytotoxic activity of NK cells
One main function of NK cells is the ability to destroy abnormal cells. The effect of
valinomycin and cereulide on freshly isolated PBLs was investigated using the Cr-
release assay with cultured K-562 as the target. This cancer cell line is especially sen-
sitive to killing by natural killer cells. Valinomycin from two different origins were
used. One valinomycin preparation was of commercial grade, purified from S. tsusi-
maensis, and the other was purified from a S. griseus strain isolated from a Finnish
moisture damaged indoor environment. Considering the different species of producer
bacteria, the two valinomycin preparations may have contained different impurities.
Cereulide was purified from Bacillus cereus strains connected to food poisoning. The
purity of PBLs was sufficient for the experiments because NK cells are the only cell
type that kill target cells without prior activation.
4.2.1 Valinomycin effects
Valinomycin inhibited NK cell cytotoxicity efficiently as measured by the reduction
in the percentage of cytotoxicity. The inhibition varied between 10 % and 60 %. The
kinetics of this inhibition was fast, the maximal effect already seen at the 1 min time
point. Spontaneous release (= in absence of NK cells) of chromium from valinomy-
cin-treated K-562 target cells was similar to that from untreated K-562 target cells. The
observed inhibition of NK cell killer activity depended on the dose of valinomycin.
Small doses, 20 to 50 ng/ml, impaired killing by 10 to 30 %, and doses over 70 ng/
ml, inhibited cytotoxicity at least 50 %. Interestingly, the inhibition always remained
partial, even at high doses, 500 ng/ml (Figure 1, Paper II). The slight difference in the
effects of the two valinomycin preparations may reflect the fact that they originated
from different species and the impurities may have interfered with the biological ef-
fect of the toxins. The actual concentration of valinomycin may also have differed
slightly between the two preparations, but only slightly as there was no reflection
observed in the shapes of the dose response columns in Figure 1, Paper II.
The inhibition remained constant over the 4 h of testing, shown in Figure 8. The
maximal inhibition was reached with an exposure concentration of 70 ng/ml of vali-
nomycin. No further increase in toxicity was seen with higher concentrations (Figure
5 and Figure 1, Paper II).
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Figure 8. Kinetics of cytotoxicity inhibition of PBLs after exposure to 50 ng/ml
valinomycin. Each value represents an average of those obtained from 6 individual
donors. Group I (PBLs of 6 donors) was exposed for 1 to 20 min and group II (PBLs
of 6 donors) for 0.5 to 3 hours.
Interleukin treatment before or after toxin exposure was observed to prevent the in-
hibition of NK cell cytotoxicity, as seen in Figure 9. According to JC-1 staining results
(Figure 13), the mitochondrial membrane potential of the interleukin-stimulated,
valinomycin-treated cells was affected as much as the mitochondrial membrane po-
tential of the noninterleukin- stimulated, valinomycin-treated cells. This indicates that
interleukins did not protect the NK cells against the loss of mitochondrial transmem-
brane potential, leading to the onset of apoptosis, by the toxins. The fact that the in-
terleukins activated the cytotoxicity of the NK cells, even after the toxin exposure,
means that the cytotoxic machinery of NK cells probably utilized the remaining ATP
pool, which is present in the effector cells (Table 1, Paper IV). According to the results
shown in table 1, paper IV the toxin exposure reduced the ATP content of NK cells by
25 %.
The rapidity of expression of the toxic effect of cereulide and valinomycin on the PBLs
is probably due to the high lipophilicity of these toxins, their log K
ow
:s being 5.99 and
7.46, respectively [14]. Such high lipophilicity allows the toxins to penetrate immedi-
ately through biological membranes. Other well-known lipophilic toxic compounds
are DDT (di(para-chloro-phenyl)-trichloroethane) and PCB (polychlorinated biphe-
nyls), with K
ow
 values ranging from 4.3 to 8.3 depending on the congener [86].
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Figure 9. Effects of valinomycin and of cereulide with interleukins on the NK cell
cytotoxicity. A. Treatment of interleukins 20 h followed by 2 h toxin (cereulide)
exposure; B. 2 h exposure to the toxin (valinomycin) followed by 20 h interleukin
treatment (n = 4).
The heterogeneity of NK cells (Figure 12) [41, 87] may explain the fact that some cy-
totoxicity was always detectable after the toxin treatments. An alternative explana-
tion for the residual cytotoxicity may be that the cytotoxic machinery of NK cells
became resistant to the toxins at some activation level. This activation level may vary
depending on the infection status of the host. The interleukin influence on NK cell
cytotoxicity is shown in Figure 8, where interleukin treatment before or after toxin
treatment recovered the cytotoxicity to a level as high as the original cytotoxicity.
Yet another explanation for the residual cytotoxicity is that small in concentrations of
toxins are not distributed evenly to all NK cells. This, however, is unlikely since even
very high concentrations of the toxins did not eradicate the residual cytotoxicity, as
seen in Figure 1, Paper II.
4.2.2 Cereulide effects
The present results in this thesis show that exposure to cereulide, the emetic toxin of
Bacillus cereus, partially inhibited the cytotoxic activity of NK cells. As was in the case
of valinomycin, the kinetics of the NK cell cytotoxicity inhibition by cereulide was
fastT- it occurred within the first minute of exposure. The inhibition was clear and re-
mained stabile for the following 3 hours. Data obtained during the 20 minute expo-
sures are shown in Figure 2b, Paper III.
The used cereulide preparations were purified from two different strains of Bacillus
cereus (F5881/94 and F4810/72). The effects of cereulide purified from these strains
were compared to those of valinomycin, which was included in the study as a refer-
ence toxin. The cytotoxicity of PBLs was inhibited by both preparations of cereulide,
the level of inhibition being slightly lower than that observed for valinomycin.
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The difference in the inhibiting effects of cereulide and valinomycin may rely on the
structure of cereulide, which differs from that of valinomycin. Variation between in-
dividual NK cell donors was also observed (Paper III, Figure 2a). In general, how-
ever, the results were very similar to those obtained by valinomycin.
4.3 Morphological changes in toxin treated NK cells
Valinomycin, as well as cereulide, induced distinct morphological changes in exposed
NK cells. Both toxins provoked the formation of large cytoplasmic vacuoles in NK
cells. This was easy to see by different microscopic techniques. We used ordinary light
microscopy and fluorescence microscopy, as well as scanning (SEM) and transmission
(TEM) electron microscopies.
Microscopic pictures showed that NK cells treated with valinomycin or with cereulide
displayed characteristic vacuoles, which were not observed in untreated NK cells
(Figure 10).
Figure 10. Light microscopic pictures of Giemsa stained NK cells. A. Unexposed
cells, B. cells exposed for 2 h at 37°C to valinomycin, 1000 ng/ml, C. to cereulide, 50
ng/ml , 2 h at 37°C.
Details of the vacuoles visible in the Giemsa stained NK cells, were examined with
SEM and TEM techniques. In SEM picture untreated NK cell displays typical surface
projections of the NK cells. The surface of a toxin-treated cell is different: the surface
projections were shorter and thicker, as demonstrated in Figure 3, Paper II. Cereulide
also induced similar changes on the NK cell surface (data not shown).
TEM pictures of the resting NK cells showed a large nucleus and several intact mi-
tochondria, Figure 2, Paper II and Figure 5, Paper III. An exposure of 3 h to valino-
mycin or to cereulide induced the swelling of mitochondria and distortion of mito-
chondrial cristae and of the inner membrane of purified NK cells and cells of the
NK-92 cell line. Nuclear changes were minimal, only mild condensation of chroma-
tin was seen (Figure 11 in this thesis shows only mitochondrial changes)
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Figure 11. TEM pictures of NK cell mitochondria. A. An intact mitochondrion of
NK cell. Mitochondria of B. valinomycin (100 ng/ml) and C. cereulide (100 ng/ml)
exposed NK cells.
4.4 Mitochondrial transmembrane potential changes in toxin
treated cells
NK cells were stained with the lipophilic dye JC-1, which displays the changes of the
mitochondrial membrane potential (∆ψ
m
 ). Normal mitochondria are energized and
∆ψ
m
 is high. The high ∆ψ
m
 in JC-1 stained cells is visible as a yellow fluorescence of
mitochondria, whereas the cytoplasmic membrane potential is lower and the fluores-
cence green. When the ∆ψ
m
 decreases, the intensity of the yellow fluorescence of the
mitochondria decreases or disappears.
Unexposed JC-1-stained human NK cells presented the fluorescence pattern dis-
played in Figure 12A in this thesis and in Figure 4, Paper III. NK cells exposed to a
small dose (0.1 ng/ml) of cereulide displayed a decreased intensity of yellow fluores-
cence emission. A high dose of cereulide, 500 ng/ml, caused the total disappearance
of yellow fluorescence, leaving the cells green, indicating the low ∆ψ
m
 in Figure 4,
Paper III.
Interestingly, when studying large numbers of NK cells it was later observed that a
minority of NK cells did not lose the mitochondrial ∆ψ
m
 in response to the toxin treat-
ment. This was demonstrated in fluorescence microscopy pictures taken of NK cells
exposed to 12.5 and 100 ng/ml valinomycin, in Figure 12. Those individual cells are
possibly responsible for the residual killing and production of cytokines in assays, as
described earlier in paragraphs 4.2.1 and 4.2.2.
Our attempt to phenotype the toxin resistant NK cells was unsuccessful. It will be
interesting to study sensitivity of CD56bright and CD56dim NK cells to these toxins
since these subpopulations differ dramatically in cytotoxic capacity and IFN-γ
production [87].
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Figure 12. NK cells stained with JC-1 and viewed with a fluorescence microscope.
A. Resting NK cells. Cells exposed to valinomycin at concentrations of: B. 1 ng/ml,
C. 3.1 ng/ml, D. 6.3 ng/ml, E. 12.5 ng/ml, F. 25 ng/ml, and G. 100 ng/ml.
When Hep G2 (hepatoblastoma) and HeLa (adenocarcinoma from cervix) cell lines
and the resting human NK cell were compared, the NK cells proved most sensitive
to valinomycin exposure as measured by loss of mitochondrial transmembrane po-
tential (Figure 13A). The NK-92 cell line, which resembles normal NK cells, was al-
most as sensitive to the toxic effect. HepG2 and HeLa represent parenchymic epithe-
lial cells and were more resistant to valinomycin.
These results reveal the disadvantage of the use of cultured cell lines in toxicity test-
ing: cell lines do not necessarily reflect the actual toxicity of various compounds in
vivo. Activation of NK cells with different combinations of interleukins did not pro-
tect the cells against collapse of the mitochondrial membrane potential.
4.5 Apoptosis in NK cells
To assess the role of caspase activity in apoptosis, a general caspase-inhibitor, Z-VAD-
FMK, and a specific caspase-3 inhibitor, Z-DEVD-FMK were used. Apoptosis was
measured by annexinV-FITC/ propidium iodide stainings, flow cytometry, caspase-
3 activity assays, and DNA fragmentation analyses.
4.5.1 Effects of valinomycin and cereulide
NK cells were found to be highly sensitive to the valinomycin and cereulide induced
apoptosis when compared to T cells. These results are described in Papers II, Figure
4 and III, Figure 6. The data presented in Papers II and III include both early and late
apoptosis. After 2 h of toxin treatment the apoptosis rate was measured by AnnexinV-
FITC. The proportion of apoptotic NK cells did not deviate from the control level
within 2 hours. The toxin effects appeared after 24 h, when the ratio of apoptotic cells
was double that of untreated NK cells. The ratio of early and late apoptotic cells con-
tinued to increase during the subsequent two days. At the same time similarly
treated T cells showed only a slight increase of apoptosis. These results are shown
in Figure 4, Paper II and in Figure 6, Paper III.
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Figure 13. Flow cytometric analysis of changes in the mitochondrial membrane
potential of human cell lines and resting NK cells in response to1 h valinomycin
exposure. Membrane potential was detected as yellow fluorescence of cells stained
with JC-1. A. The effect of valinomycin concentrations on the mitochondrial
membrane potential of different cell types. These NK cell values represent the
average (± S.E.) from 7 individual donors. B. Effects of 1h valinomycin (20 ng/ml)
exposure on mitochondrial membrane potentials. The figure shows results
obtained with resting NK cells, pre-incubated overnight with different
combinations of interleukins. These values represent averages (± S.E.) from 10
individual donors.
These results further suggest that NK cells are highly sensitive to the toxic effects of
cereulide and valinomycin, and therefore these toxins primarily damage the first line
of immune defence.
4.5.2 Role of caspase-3
The majority of known apoptotic pathways are caspase-3 dependent. Therefore the
caspase-3 activity of valinomycin-treated and untreated NK and T cells was meas-
ured. Interleukin-stimulated NK cells were also included because the earlier results
indicated that interleukins may protect some NK cell functions against toxin attack.
The mitochondrial changes observed in the TEM pictures suggested that caspase-3-
dependent apoptosis (see the Introduction, caspase-part) could occur in NK cells.
(Figure 2, Paper II and Figure 5, Paper III).
The results obtained with isolated resting NK cells revealed a high caspase-3 activi-
ty in the absence of activation, thus differing in this respect from T cells [71]. Treat-
ment of NK cells with the toxin or interleukin also left the caspase-3 activity unaffect-
ed. After 24 hour culturing, the caspase-3 activity of NK cells decreased, as described
in Figure 1, Paper IV. The general caspase inhibitor Z-VAD-FMK totally inhibited
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caspase-3 activity. (Figure 1, Paper IV). However, flow cytometric analysis of Z-VAD-
FMK and/or valinomycin-treated NK cells showed that general caspase inhibitor
could not prevent early or late apoptosis nor necrosis. These results suggested that a
caspase-3-independent pathway of apoptosis exists in NK cells (Figure 2, Paper IV).
However, somewhat contradicting results were obtained from the DNA analyses. One
marker of apoptosis is the subgenomic DNA peak, subG1. The subG1 analysis of
valinomycin-treated NK cells indicated that caspase inhibitor partly inhibited valin-
omycin- induced NK cell apoptosis. In the presence of general caspase inhibitor, the
subG1 peak decreased from 22 % to only 9 %, shown in Figure 6, Paper IV. Interest-
ingly, DNA ladder analysis [88] further showed that inhibition of caspases prevent-
ed the ladder formation neither in valinomycin treated nor in anti-Fas induced NK
cells as shown in Figure 6, Paper IV. Taken together, these results suggest that valin-
omycin induces in NK cells two types of apoptosis simultaneously; one caspase-3-
dependent and one caspase-3-independent. The caspase-3 independent apoptosis
could, for instance, be endo-G-mediated (Figure 7) [79]. When valinomycin induced
clear mitochondrial damages, it is possible that the endo-G was released from the
mitochondrial matrix and caused the ladder formation of DNA. The same phenom-
enon likely occurs with cereulide.
4.6 Other effects of toxins on NK cells
Although the exact mechanism of NK cell cytotoxicity inhibition by the toxins is not
clear, several explanations can be suggested on the basis of the current results. One
explanation is the toxin-induced inhibition of ATP production, at least partly caused
by disruption of mitochondria (Table 1, Paper IV). The shrinking reservoir of ATP may
hamper the operation of the cytotoxic apparatus and the mobility of NK cells. Another
mechanism of inhibition is simply the reduction of effector cell numbers through
apoptosis. When the effect of general caspase inhibitor Z-VAD-FMK was tested on NK
cell proliferation, IFN-γ production, and cytotoxicity, a modest increase in these ac-
tivities was detected, as described in Paper IV. These observations suggest that cas-
pase-3 has only a restricted role in NK cell biology; it is most probably involved in the
control of NK cell life span and homeostasis [89]. This may function as part of the
immune system to avoid autoimmune diseases.
4.7 Possible dangers of human exposure to potassium ionophores
Cereulide exposure usually comes from food. Improper conditions of food storage
may permit cereulide production in food, thus increasing the risk of cereulide expo-
sure. These foods are usually nonrefrigerated and stored under conditions that allow
moisture retention (i.e. a plastic bag). Under such conditions even a low contamina-
tion by cereulide producing B. cereus may also result in levels of cereulide harmful to
consumer’s health. The cereulide dose, which causes acute emetic disease in human
is ≤ 8 µg/kg body weight [90]. Toxin risks are associated with reheated foods, meals,
or meal residues stored nonrefrigerated for hours or days, for instance pasta, vege-
tables, and steamed or cooked rice. Furthermore, the presently applied shelf life of
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bakery products ranges from 4 to 75 days (depending on the type of product). Recent-
ly, cereulide-producing B. cereus strains were also found in indoor dust and indoor
materials of moisture-affected buildings [91], indicating an exposure route by inha-
lation.
The present study showed that the NK cells capacity to kill abnormal cells is impaired
after toxin exposure. If such exposure is long lasting, as may occur in moisture dam-
aged buildings, the impaired NK function may lead to a compromised immune de-
fence towards microbial infections and cancer.
In industrialized countries human exposure to the other Streptomyces produced po-
tassium ionophores lasalocid, salinomycin, and narasin (Table 1) is likely to occur,
since these substances are used on a large scale as animal feed additives (Table 2). In
Finland, the annual usage of these substances in animal feeds averaged during 1000
kg to 6000 kg in 1996 to 2002 [11]. Human exposure may result from residues remain-
ing in foodstuffs of animal origin [8, 13] and it may occur in occupational situations
by air or skin contact (animal feed handlers and livestock farmers). In a boar sperma-
tozoan assay for mitochondrial toxicity, lasalocid was found to be similarly toxic as
cereulide and valinomycin. Salinomycin and narasin were also toxic to mitochondria
but less potent (D. Hoornstra, unpublished information). Since these substances are
also lipophilic, and thus likely to passively permeate into tissues and cells, effects on
immune cells may expected to be similar to those observed for valinomycin and
cereulide in the present thesis.
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5.1 IFN-α and IL-18 enhance IFN-γ production by purified resting human NK cells
in a synergistic manner. Additionally, the combination of IL-12 and IL-18 induc-
es high IFN-γ production. IL-12, IL-15 and IL-18 are synergistic in the induction
by IFN-γ and GM-CSF production by NK cells. The production IFN-γ and GM-
CSF by NK cells is inhibited by two environmental toxins, valinomycin and
cereulide. Cereulide is slightly less toxic than valinomycin.
5.2 Valinomycin and cereulide are more toxic to NK cells than to peripheral blood
T cells and monocytes.
5.3 Valinomycin partially inhibits the cytotoxicity of NK cells, and the kinetics of
the effect is very rapid. Also cereulide inhibits partially and very quickly the
cytotoxicity of NK cells — very similar to valinomycin.
5.4 Valinomycin and cereulide induce mitochondrial swelling of NK cells.
5.5 A minority of NK cells do not lose the mitochondrial transmembrane potential
upon toxin treatment. These residual cells are cytotoxic and produce cytokines
even after toxin exposure. NK cells lost mitochondrial membrane potential at
exposure to lower valinomycin concentrations as compared with other human
cell types.
5.6 Valinomycin and cereulide induce apoptosis of NK cells. The apoptotic
effect on T cells is much weaker.
Valinomycin exposure does not affect the caspase-3 activity of NK cells
and T cells.
Valinomycin induces simultaneously both caspase-3-dependent and
caspase-3-independent apoptosis in NK cell.
5.7 Humans can be exposed to various microbially produced potassium iono-
phores derived from food or environment.
The present study concentrated on two major topics. Firstly, what are the responses
induced by two K+ ionophoric toxins, valinomycin and cereulide, on NK cell viabil-
ity and functions. Secondly, how IFN-α and different interleukin combinations affect
the IFN-γ production by NK cell.
NK cells represent the first line of immune defence and therefore the impairment of
optimal NK cell functions, shown in the present study, may subsequently lead to a
compromised defence against microbial invasion and/or neoplastic disease. Dimin-
ished IFN-γ production by NK cells, due to toxin action, also may enhance hypersen-
sitivity reactions. As compared with other cells of the immune system, NK cells were
particularly sensitive to the tested potassium ionophoric toxins. NK cytotoxicity as-
say should be considered as a tool for investigating toxins potentially encountered in
the environment and/or in food.
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